fliu2	10.1016/j.bcp.2007.12.021	<http://dx.doi.org/10.1016/j.bcp.2007.12.021>; rel="canonical", <https://api.elsevier.com/content/article/PII:S0006295208001652?httpAccept=text/xml>; version="vor"; type="text/xml"; rel="item", <https://api.elsevier.com/content/article/PII:S0006295208001652?httpAccept=text/plain>; version="vor"; type="text/plain"; rel="item", <https://www.elsevier.com/tdm/userlicense/1.0/>; version="tdm"; rel="license"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1016/j.bcp.2007.12.021"><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0006-2952"><owl:sameAs>urn:issn:0006-2952</owl:sameAs><j.0:title>Biochemical Pharmacology</j.0:title><j.1:issn>0006-2952</j.1:issn><j.2:issn>0006-2952</j.2:issn></j.2:Journal></j.0:isPartOf><j.2:pageStart>2080</j.2:pageStart><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/qiang-chen-650yxd5fm1h0"><j.3:name>Qiang Chen</j.3:name><j.3:familyName>Chen</j.3:familyName><j.3:givenName>Qiang</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/wang-qing-liu-650yxd5fm1h0"><j.3:name>Wang-Qing Liu</j.3:name><j.3:familyName>Liu</j.3:familyName><j.3:givenName>Wang-Qing</j.3:givenName></j.3:Person></j.0:creator><j.0:publisher>Elsevier BV</j.0:publisher><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/fang-liu-650yxd5fm1h0"><j.3:name>Fang Liu</j.3:name><j.3:familyName>Liu</j.3:familyName><j.3:givenName>Fang</j.3:givenName></j.3:Person></j.0:creator><j.2:volume>75</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/hui-jing-chen-650yxd5fm1h0"><j.3:name>Hui-Jing Chen</j.3:name><j.3:familyName>Chen</j.3:familyName><j.3:givenName>Hui-Jing</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jie-yu-li-650yxd5fm1h0"><j.3:name>Jie-Yu Li</j.3:name><j.3:familyName>Li</j.3:familyName><j.3:givenName>Jie-Yu</j.3:givenName></j.3:Person></j.0:creator><j.2:doi>10.1016/j.bcp.2007.12.021</j.2:doi><j.1:startingPage>2080</j.1:startingPage><j.1:doi>10.1016/j.bcp.2007.12.021</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/christiane-garbay-650yxd5fm1h0"><j.3:name>Christiane Garbay</j.3:name><j.3:familyName>Garbay</j.3:familyName><j.3:givenName>Christiane</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>75</j.1:volume><j.1:endingPage>2091</j.1:endingPage><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/michel-vidal-650yxd5fm1h0"><j.3:name>Michel Vidal</j.3:name><j.3:familyName>Vidal</j.3:familyName><j.3:givenName>Michel</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="info:doi/10.1016/j.bcp.2007.12.021"/><j.0:title>The cytotoxicity of a Grb2-SH3 inhibitor in Bcr-Abl positive K562 cells</j.0:title><owl:sameAs rdf:resource="doi:10.1016/j.bcp.2007.12.021"/><j.0:identifier>10.1016/j.bcp.2007.12.021</j.0:identifier><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#gYearMonth" >2008-06</j.0:date><j.2:pageEnd>2091</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jian-yin-lin-650yxd5fm1h0"><j.3:name>Jian-Yin Lin</j.3:name><j.3:familyName>Lin</j.3:familyName><j.3:givenName>Jian-Yin</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/yun-bin-ye-650yxd5fm1h0"><j.3:name>Yun-Bin Ye</j.3:name><j.3:familyName>Ye</j.3:familyName><j.3:givenName>Yun-Bin</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
